ConductScience.org, home

Paper40927152

Improving Brain Tumor Treatment through Nanotechnology and Proton Therapy Using Laser-driven Accelerators through GEANT4 Simulation.

Kavehnia M and 2 others. Indian J Nucl Med, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Improving Brain Tumor Treatment through Nanotechnology and Proton Therapy Using Laser-driven Accelerators through GEANT4 Simulation. Papers, record 40927152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40927152

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Improving Brain Tumor Treatment through Nanotechnology and Proton Therapy Using Laser-driven Accelerators through GEANT4 Simulation.
PubMed
Journal
Indian J Nucl Med
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-09-12
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kavehnia MMehdi
2Sadeghi HHossein
3Hosseinimotlagh SNSeyede Nasrin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139025943Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours.Nat Biomed Eng2024https://conductscience.org/library/papers/39025943PubMed
228976361RBE and related modeling in carbon-ion therapy.Phys Med Biol2017https://conductscience.org/library/papers/28976361PubMed
337174022Image-Guided Proton Therapy: A Comprehensive Review.Cancers (Basel)2023https://conductscience.org/library/papers/37174022PubMed
426155318Nanoparticles for Radiation Therapy Enhancement: the Key Parameters.Theranostics2015https://conductscience.org/library/papers/26155318PubMed
536902132Mechanisms of Nanoscale Radiation Enhancement by Metal Nanoparticles: Role of Low Energy Electrons.Int J Mol Sci2023https://conductscience.org/library/papers/36902132PubMed
62946403A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.Cancer Res1986https://conductscience.org/library/papers/2946403PubMed
725953956Biological modeling of gold nanoparticle enhanced radiotherapy for proton therapy.Phys Med Biol2015https://conductscience.org/library/papers/25953956PubMed
828150217Nanoparticle-Mediated X-Ray Radiation Enhancement for Cancer Therapy.Methods Mol Biol2017https://conductscience.org/library/papers/28150217PubMed
918644191Radiotherapy enhancement with gold nanoparticles.J Pharm Pharmacol2008https://conductscience.org/library/papers/18644191PubMed
1036873996Nanoparticle-based radiosensitization strategies for improving radiation therapy.Front Pharmacol2023https://conductscience.org/library/papers/36873996PubMed
1127399787Protection against Radiotherapy-Induced Toxicity.Antioxidants (Basel)2016https://conductscience.org/library/papers/27399787PubMed
1221915155Enhanced relative biological effectiveness of proton radiotherapy in tumor cells with internalized gold nanoparticles.Appl Phys Lett2011https://conductscience.org/library/papers/21915155PubMed
1329125831Nanoparticle radio-enhancement: principles, progress and application to cancer treatment.Phys Med Biol2018https://conductscience.org/library/papers/29125831PubMed
1423201628Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles.Phys Med Biol2012https://conductscience.org/library/papers/23201628PubMed
1531725910Gold nanoparticle enhanced proton therapy: A Monte Carlo simulation of the effects of proton energy, nanoparticle size, coating material, and coating thickness on dose and radiolysis yield.Med Phys2020https://conductscience.org/library/papers/31725910PubMed
1635110613Comparing Geant4 physics models for proton-induced dose deposition and radiolysis enhancement from a gold nanoparticle.Sci Rep2022https://conductscience.org/library/papers/35110613PubMed
1736160180A Review of Proton Therapy - Current Status and Future Directions.Precis Radiat Oncol2022https://conductscience.org/library/papers/36160180PubMed
1837704633Facile preparation of silver based radiosensitizers via biomineralization method for enhanced in vivo breast cancer radiotherapy.Sci Rep2023https://conductscience.org/library/papers/37704633PubMed
1925415297Comparing gold nano-particle enhanced radiotherapy with protons, megavoltage photons and kilovoltage photons: a Monte Carlo simulation.Phys Med Biol2014https://conductscience.org/library/papers/25415297PubMed
2025361443Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.Phys Med Biol2014https://conductscience.org/library/papers/25361443PubMed

See all 30 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40927152

GET https://conductscience.org/api/papers/v1/40927152/references?page=2